CARDIOL THERAPEUTICS INC-A (CRDL) Stock Analyst Ratings
NASDAQ:CRDL - Nasdaq - CA14161Y2006 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CRDL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.91. This target is 475.65% above the current price.
CRDL was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRDL.
In the previous month the buy percentage consensus was at a similar level.
CRDL was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | Roth MKM | Initiate | Buy |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Initiate | Buy |
| 2023-08-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-05-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2021-12-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-12-03 | Canaccord Genuity | Initiate | Buy |